Co-Authors
This is a "connection" page, showing publications co-authored by Yaokai Chen and Yan-Qiu Lu.
Connection Strength
0.668
-
Predictive factors of progression to severe COVID-19. Open Med (Wars). 2020; 15(1):805-814.
Score: 0.225
-
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study. Front Pharmacol. 2020; 11:1071.
Score: 0.223
-
Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial. Chin Med J (Engl). 2020 May 05; 133(9):1080-1086.
Score: 0.220